NCT00624741No Longer Available不适用
Compassionate Use of Pergolide as Adjunctive Therapy to Levodopa/Carbidopa for Treating Parkinson's Disease
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- No Longer Available
研究概览
简要总结
This compassionate use study is designed to monitor safety in patients who have been doing well on pergolide therapy, wish to continue treatment, and have not been able to tolerate alternative treatments.
研究设计
- 研究类型
- Expanded Access
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosed with Parkinson's disease and treated successfully with pergolide in the recent past
- •Attempt to taper off pergolide was unsuccessful and patient was unable to change to other forms of therapy for Parkinson's disease
- •No evidence of cardiovalvular disease by echocardiogram conducted within 60 days prior
排除标准
- •History or current diagnosis of cardiac valvulopathy
- •Inability to undergo echocardiograms every 6 months while receiving pergolide
- •Hypersensitivity to pergolide or other ergot derivatives
研究者
相似试验
已完成
不适用
An Observational Study of Peginterferon (e.g. Pegasys)-Based Direct Acting Antiviral Triple Therapy in Patients With Chronic Hepatitis C Genotype 1Hepatitis C, ChronicNCT01508130Hoffmann-La Roche672
已完成
3 期
Pegylated Interferon-alpha-2a in Patients With Malignant Melanoma Stage IIA-IIIBMelanomaNCT00204529University Hospital Tuebingen901
已完成
3 期
A Phase 3 Study of Pembrolizumab + Epacadostat or Placebo in Subjects With Unresectable or Metastatic Melanoma (Keynote-252 / ECHO-301)MelanomaNCT02752074Incyte Corporation706
终止
2 期
Pegylated Interferon Alpha-2b in Early Primary MyelofibrosisMyelofibrosisNCT01758588Weill Medical College of Cornell University8
已完成
2 期
Pergolide Treatment for Substance Abusers - 4Cocaine-Related DisordersSubstance-Related DisordersNCT00000269National Institute on Drug Abuse (NIDA)